These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9524836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
    Perez CM, Kubak BM, Cryer HG, Salehmugodam S, Vespa P, Farmer D.
    Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A, Low DE, McGeer A, Kotb M.
    Adv Exp Med Biol; 1997 Jan; 418():563-6. PubMed ID: 9331714
    [No Abstract] [Full Text] [Related]

  • 5. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
    Stevens DL.
    Clin Infect Dis; 2003 Aug 01; 37(3):341-3. PubMed ID: 12884157
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous immunoglobulin therapy for toxic shock syndrome.
    Barry W, Hudgins L, Donta ST, Pesanti EL.
    JAMA; 1992 Jun 24; 267(24):3315-6. PubMed ID: 1597914
    [Abstract] [Full Text] [Related]

  • 7. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Abinun M, Cant AJ.
    Lancet; 1994 Jan 29; 343(8892):300. PubMed ID: 7905129
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
    Cawley MJ, Briggs M, Haith LR, Reilly KJ, Guilday RE, Braxton GR, Patton ML.
    Pharmacotherapy; 1999 Sep 29; 19(9):1094-8. PubMed ID: 10610017
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
    Arends JE, Harkisoen S.
    Clin Infect Dis; 2015 Jan 15; 60(2):324. PubMed ID: 25313253
    [No Abstract] [Full Text] [Related]

  • 11. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.
    Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A.
    Clin Infect Dis; 2014 Sep 15; 59(6):851-7. PubMed ID: 24928291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
    Parks T, Wilson C, Curtis N, Norrby-Teglund A, Sriskandan S.
    Clin Infect Dis; 2018 Oct 15; 67(9):1434-1436. PubMed ID: 29788397
    [Abstract] [Full Text] [Related]

  • 20. Necrotizing fasciitis.
    Cherneski CL, Embil JM.
    Saudi Med J; 2001 Jul 15; 22(7):565-8. PubMed ID: 11479634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.